Ocular Therapeutix Cash Flow Statement (2013-2026) | OCUL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-21.88M	-21.18M	-19.72M	-19.50M	-21.54M	-23.06M	-20.79M	-23.75M	-21.81M	-21.43M	-22.74M	-31.75M	-40.75M	-43.57M	-49.01M	-63.08M	-67.20M	-67.97M	-65.25M	-90.07M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)	4.29M	3.76M	3.84M	4.21M	4.28M	4.24M	4.23M	4.57M	4.41M	4.51M	4.33M	7.98M	11.29M	6.64M	7.20M	10.46M	9.68M	11.69M	11.36M	15.58M
Gains from Sales and Divestitures (Quarter)											0.39M				1.28M				1.55M
Gains from Investment Securities (Quarter)	0.46M		6.78M	2.62M	0.12M	0.21M		0.00M	3.24M	1.08M	0.27M	0.99M	0.73M	1.84M	19.89M	1.05M	0.03M	0.26M	18.35M	0.42M
Non-cash Items (Quarter)			13.28M				0.01M				3.36M				41.57M				10.85M
Cash from Operations (Quarter)	-20.06M	-12.98M	-15.15M	-18.60M	-10.88M	-13.17M	-16.96M	-19.97M	-20.07M	-7.73M	-22.45M	-33.89M	-24.80M	-36.56M	-39.43M	-44.67M	-55.24M	-50.73M	-54.25M	-65.99M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)	1.15M	1.16M	1.19M	1.19M	1.21M	1.23M	1.24M	1.23M	1.25M	2.07M	1.55M	1.97M	0.57M	0.62M	0.58M	1.44M	0.71M	0.76M	0.49M	1.38M
Depreciation & Amortization (CF) (Quarter)	0.61M	0.59M	0.57M	0.56M	0.55M	0.51M	0.49M	0.48M	0.65M	0.89M	0.96M	0.92M	0.96M	0.96M	0.95M	0.98M	1.03M	1.07M	1.25M	1.28M
Change in Working Capital
Change in Receivables (Quarter)	5.10M	0.82M	1.58M	2.07M	-2.73M	-0.68M	1.52M	-0.20M	6.18M	-3.72M	2.59M	0.37M	3.69M	0.00M	2.15M	-7.17M	5.19M	0.36M	-0.12M	-6.30M
Change in Inventory (Quarter)	-0.01M	0.11M	0.03M	0.11M	0.14M	0.04M	0.43M	0.29M	-0.06M	0.05M	0.05M	0.27M	-0.03M	-0.14M	0.64M	0.23M	-0.23M	0.45M	0.08M	0.17M
Change in Account Payables (Quarter)	-0.27M	0.17M	0.37M	-1.11M	0.30M	1.31M	-1.12M	1.02M	-1.34M	0.25M	0.66M	1.69M	-2.42M	0.30M	0.11M	0.01M	1.73M	-1.27M	-1.35M	3.72M
Change in Accured Expenses (Quarter)	2.04M	2.60M	0.19M	-3.05M	1.10M	1.65M	1.94M	-2.63M	2.05M	2.60M	-1.25M	-14.03M	7.86M	5.60M	4.21M	-5.14M	2.84M	5.38M	2.18M	-8.44M
Investing Activities
Capital Expenditures (Quarter)	-0.00M	0.56M	0.63M	0.28M	-0.03M	0.23M	3.24M	0.65M	4.72M	0.26M	-5.61M	0.26M	0.74M	-0.92M	0.04M	1.93M	1.25M	5.99M	-8.00M	1.33M
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)	-0.13M	-0.28M	-0.63M	-0.28M	-0.49M	-0.79M	-2.15M	-3.38M	-1.99M	-0.26M	-0.46M	-0.26M	-0.74M	-0.09M	-0.20M	-1.93M	-1.11M	-5.99M	-2.84M	-4.66M
Financing Activities
Other financing activities (Quarter)
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Long-Term Debt Repayments (Quarter)	2.08M
Change in Capital Stock
Shares Issued (Quarter)	0.54M	-1.25M	2.10M	0.13M	0.35M		0.03M	0.08M	8.82M	0.71M	0.01M	316.35M	-309.78M	-6.08M	0.52M	4.18M	94.03M	94.03M	521.98M	0.29M
Misc.
Cash from Financing Activities (Quarter)	2.67M	0.68M	0.67M	0.13M	0.49M	0.37M	0.46M	0.08M	9.64M	51.94M	108.17M	321.22M	2.20M	4.18M	4.51M	4.18M	97.81M	10.36M	449.38M	0.29M
Change in Cash (Quarter)	-17.52M	-12.58M	-15.12M	-18.75M	-10.88M	-13.59M	-18.65M	-23.27M	-12.42M	43.94M	85.26M	287.08M	-23.35M	-32.47M	-35.12M	-42.42M	41.45M	-46.36M	392.29M	-70.36M
Free Cash Flow (Quarter)	-20.05M	-13.54M	-15.78M	-18.88M	-10.85M	-13.40M	-20.20M	-20.62M	-24.80M	-7.99M	-16.84M	-34.14M	-25.54M	-35.64M	-39.47M	-46.60M	-56.48M	-56.72M	-46.25M	-67.32M
Net Cash Flow (Quarter)	-17.52M	-12.58M	-15.12M	-18.75M	-10.88M	-13.59M	-18.65M	-23.27M	-12.42M	43.94M	85.26M	287.08M	-23.35M	-32.47M	-35.12M	-42.42M	41.45M	-46.36M	392.29M	-70.36M

Research Tools

Ocular Therapeutix Cash Flow Statement (2013-2026) | OCUL

Create an account

Sign In

Reset Password